Results 191 to 200 of about 1,863,875 (293)
Transjugular Intrahepatic Portosystemic Shunt-Related Complications and Practical Solutions [PDF]
Renato Ripamonti +3 more
openalex +1 more source
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
Understanding Risk in Emergent Reconstructive Flap Surgery. [PDF]
Jerliu A +4 more
europepmc +1 more source
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim +18 more
wiley +1 more source
Expanding the role of robotic surgery: Non-inferiority of robot-assisted radical cystectomy in overweight patients with bladder cancer. [PDF]
Kohler J +12 more
europepmc +1 more source
Department of Internal Medicine, Asan Medical Center, Seoul, South Korea +10 more
openalex +1 more source
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry +16 more
wiley +1 more source
Complicated diaphragmatic hernia post laparoscopic Nissen fundoplication: a case report. [PDF]
Maher A, Tayel A, Darwesh K.
europepmc +1 more source
Pleuro-Pulmonary Complications of Rheumatoid Arthritis [PDF]
John Corcoran +3 more
openalex +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source

